Theorem Clinical Research

Sanofi

Sanofi, Evotec collaborate to reinforce biomedical research in Toulouse

Wednesday, March 25, 2015 02:47 PM

Sanofi has signed a strategic collaboration agreement with Evotec, a drug discovery alliance and development partnership company, for scientific activities at the Sanofi R&D site in Toulouse (Haute-Garonne), France. This strategic collaboration aims to sustain a high level of scientific and technological activities, maintain jobs and attract new talent and projects to the site.

More... »

Quest Diagnostics

Evotec, Sanofi ink agreement for multi-component alliance

Friday, March 20, 2015 02:19 PM

Evotec, a drug discovery alliance and development partnership company based in Germany, has signed an agreement for a major multi-component strategic alliance over the next five years with Sanofi. The transaction is expected to close March 31.

More... »


Catalent launches Quality, Product Development & Regulatory Affairs organization

Thursday, March 19, 2015 02:55 PM

Catalent Pharma Solutions, a Somerset, N.J.-based global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has formed the Quality, Product Development & Regulatory Affairs organization, established to build upon Catalent’s experience in new product development, regulatory excellence, reliable supply and quality. Sharon Johnson, senior vice president, global quality & regulatory affairs, will head up Catalent’s new organization.

More... »

Moderna appoints Tal Zaks as chief medical officer

Thursday, March 19, 2015 01:22 PM

Moderna Therapeutics, a developer of messenger RNA (mRNA) Therapeutics across a range of therapeutic applications, has announced that Tal Zaks, M.D., Ph.D., will join Moderna's executive leadership team as chief medical officer.

More... »

New immunotechnology center MI-mAbs launched

Monday, March 16, 2015 01:48 PM

MI-mAbs, a new immunotechnology center designed to accelerate the development of new immunotherapy antibodies against cancer and inflammatory disease and founding member of the France-based Marseille Immunopole (MI) cluster, has announced the signature of the consortium agreement sealing the commitment of its founders: Aix-Marseille Universite (AMU) and its private subsidiary Protisvalor, CNRS, Inserm, the Institute Paoli-Calmettes (IPC); three of their research centers (the Centre d'Immunologie de Marseille-Luminy, the Cancer Research Center of Marseille and the Center for Immunophenomics); Innate Pharma, a European immuno-oncology company; and Sanofi.

More... »

Illumina, Merck Serono collaborate to expand companion diagnostics for oncology

Wednesday, March 11, 2015 12:22 PM

Illumina, a San Diego-based provider of sequencing and array-based technologies, has formed a collaboration with Merck Serono, the biopharmaceuticals business of Merck, based in Darmstadt, Germany, to develop a universal next-generation sequencing (NGS)-based oncology diagnostic.

More... »

SynteractHCR expands senior management team

Wednesday, March 4, 2015 08:47 AM

San Diego-based CRO SynteractHCR has hired Etienne Drouet as vice president, strategic development. This is a new position created to augment the depth of the company’s oncology and complex trial expertise.

More... »

Sanofi appoints Olivier Brandicourt CEO

Monday, February 23, 2015 01:04 PM

Sanofi’s board of directors unanimously has appointed Olivier Brandicourt CEO.

More... »

Sanofi, Lead Pharma partner to develop treatments for autoimmune diseases

Wednesday, February 18, 2015 11:55 AM

Sanofi has entered into a research collaboration and license agreement with Dutch biotech Lead Pharma to discover, develop and commercialize small-molecule therapies directed against the nuclear hormone receptors called ROR gamma t to treat a broad range of autoimmune disorders, including rheumatoid arthritis, psoriasis and inflammatory bowel disease, which are among the most common.

More... »

PharmaTimes clinical research awards to be presented Feb. 26

Thursday, February 12, 2015 03:33 PM

The 2015’s PharmaTimes Clinical Researcher of the Year—The Americas awards will be presented Feb. 26 in North Carolina.

More... »


CWWeekly

March 30

Icon, Carnegie Mellon partner to research ways to improve study patients' understanding of Informed Consent

Veeva launches OpenKey, partner program to unlock difficult access to, restrictions on customer reference data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs